[CBAY] YoY Quarter Result on 31-Dec-2018 [#Q4]

Stock
[CBAY] CymaBay Therapeutics, Inc.
Announcement Date
28-Feb-2019
Financial Year
2018
Quarter
31-Dec-2018 [#Q4]
Profit Trend
QoQ- -4.77%
YoY- -285.66%
Quarter Report
CBAY's Result
CBAY's Financial Summary
View:
Show?
Quarter Result
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Revenue 0 0 0 0 5,207 0 0 -
PBT -26,543 -15,751 -29,413 -19,449 -5,043 -6,952 -5,979 28.17%
Tax 5,139 -123 -150 1,106 -543 361 465 49.19%
NP -26,543 -15,751 -29,413 -19,449 -5,043 -6,952 -5,979 28.17%
Tax Rate - - - - - - - -
Total Cost 26,543 15,751 29,413 19,449 10,250 6,952 5,979 28.17%
Ratio Analysis
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
NP Margin 0.00 0.00 0.00 0.00 -96.85 0.00 0.00 -
Per Share
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
EPS -0.38 -0.23 -0.43 -0.31 -0.09 -0.26 -0.26 6.52%
EPS Diluted -0.38 -0.23 -0.43 -0.31 -0.09 -0.26 -0.26 6.52%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.